Atrys Health Agrees Eight Million Euro Loan with Inveready CEO

✦ Meridian Analysis

Atrys Health, a European provider of diagnostic and digital health services, has signed an eight‑million‑euro loan agreement with the chief executive of Inveready, who also sits on Atrys’ board. The financing is intended to address the upcoming maturity of Atrys’ convertible notes. The exact terms, security package and interest rate were not disclosed. Inveready closed a €20 million search‑fund vehicle and led a €3.5 million round for biotech Hawk Biosystems. What remains undisclosed are the loan’s pricing, any covenants or collateral, the maturity profile and whether the facility includes an equity kicker or conversion feature. Information on the advisers engaged, regulatory approvals required and the timetable for a subsequent refinancing or note conversion would also be of interest to deal professionals monitoring the evolution of Atrys’ capital structure.

The Meridian Weekly